WEBULL
WebtradeDownload

Nippon Shinyaku (TSE:4516) Stock Price Trails A Profit Recovery Story

Simply Wall St · 2d ago

Nippon Shinyaku stock has been drifting, with the 90 day return down about 13%, yet the latest earnings land with a very different message. Q1 2027 profit sits a little above ¥10,000m and basic earnings per share are about ¥150, numbers that keep trailing 12 month earnings growth in positive territory and support a P/E near 7.6x. The market is still fixated on forecasts for falling earnings and a discounted dividend story. The real question after this print is whether that gloom still fits the actual profit trend investors see today.

Is Nippon Shinyaku trading at a genuine discount, or just looking cheap beside that lower DCF estimate and forecast earnings decline? Compare the market price with our valuation analysis for Nippon Shinyaku.

Q1 2027 Earnings Summary

  • Revenue (Q1 2027 vs Q1 2026): ¥49,066m vs. ¥39,546m (up about 24%)
  • Net Income (Excl. Extra Items, Q1 2027 vs Q1 2026): ¥10,109m vs. ¥8,255m (up about 23%)
  • Basic EPS (Q1 2027 vs Q1 2026): ¥150.08 vs. ¥122.52 (up about 22%)
  • Trailing 12 Month Basic EPS (Q1 2027 vs Q1 2026): ¥468.58 vs. ¥453.53 (up about 3%)

Prefer clean charts to another wall of earnings tables and ratios? See Nippon Shinyaku's full financial picture with a simple visual view of its recent earnings trend and profitability in the company report for Nippon Shinyaku.

TSE:4516 Trailing 12-Month Earnings & Revenue History as at Aug 2026
TSE:4516 Trailing 12-Month Earnings & Revenue History as at Aug 2026

Nippon Shinyaku earnings keep profit trend intact

For investors looking at the bullish angle, Nippon Shinyaku now has Q1 2027 revenue of ¥49,066m and net income of ¥10,109m, both above the prior year. Basic EPS of about ¥150 and trailing 12 month EPS above ¥460 keep earnings in positive territory. That supports a case that the core pharma and functional food businesses are still generating profit, even while the share price is down about 13% over 90 days.

Recent share drift still flags real concerns

The bearish narrative is not fully dismissed. Profit and return on equity previously softened in FY26 and management guided to a rebound, so investors were already looking for better numbers. The Q1 EPS uplift versus last year helps, but a 30 day share price decline of about 13% suggests the market is still cautious. That points to lingering concern that guided profit recovery and rare disease pipeline developments may need more time to translate into stronger conviction.

Compare Nippon Shinyaku's steady profit trend with that 13% share price drop and see whether analysts think the story lines up with their targets. Reveal how the street is positioned with the consensus price target analysis for Nippon Shinyaku.

Stay Ahead With Nippon Shinyaku

If Nippon Shinyaku's mix of solid recent earnings and a softer share price has your attention, register for free with Simply Wall St and add it to a Watchlist so you can track price against fair value and wait for a level that fits your plan. Once you decide to own it, keep a clear view of how Nippon Shinyaku fits with your other holdings using the Portfolio Command Center that focuses on the most important updates. For a longer term view, compare your thinking with thousands of other investors through the Community and see how sentiment is shifting over time. This way you can spot potential catalysts and risks earlier and stay a step ahead of the wider market.

Seeking Alternatives Beyond Nippon Shinyaku?

Fresh ideas can move quickly and you may not want the next breakout slipping away while you stay focused on one stock. Scan these under the radar picks before the crowd and consider your options.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.